RBCC Explores New Cures for Cancer, Brain Injuries & Headaches

NOKOMIS, Fla.--(BUSINESS WIRE)-- Cutting-edge stem cell research is
producing new breakthroughs that could potentially
revolutionize the treatment of currently incurable diseases
from cancer to brain injuries to headaches. Rainbow Coral Corp.
(OTCBB:RBCC.OB
-
News), an emerging biotechnology company, is hard at work
identifying and targeting promising new stem-cell treatments
for commercialization.

As the world’s population ages and the economic might of
emerging countries such as China and India blossoms, the market
is increasing daily for new and effective cures to old
ailments. RBCC plans to capitalize on recent
growth in the biosciences sector by commercializing
advanced-stage research with the potential to produce new
treatments.

RBCC is aiming high. The company’s current target, n3D
Biosciences, has developed a breakthrough cell-culturing system
that allows scientists to grow 3D stem cells that behave much
more similarly to cells found in the body. This product may
directly assist with advanced discoveries to find cures for
common injuries and diseases.

With the help of its new allies in BioHouston, RBCC plans to
identify new targets on the cutting-edge of biotechnology for
acquisition and joint venture.

Through its biotech division, Rainbow BioSciences, RBCC is
working to develop new medical and research technology
innovations to compete alongside companies such as Cell
Therapeutics, Inc.(NASDAQ: CTIC), Biogen Idec Inc.
(NASDAQ: BIIB), Abbott Laboratories (NYSE:
ABT -
News) and Elan Corp. (NYSE: ELN).

For more information on Rainbow BioSciences’ biotechnology
initiative, please visit
http://www.rainbowbiosciences.com/investors.

About Rainbow BioSciences

Rainbow BioSciences, LLC, is a wholly owned subsidiary of
Rainbow Coral Corp. (OTCBB:RBCC.OB
-
News). The company continually seeks out new partnerships
with biotechnology developers to deliver profitable new medical
technologies and innovations. For more information on our
growth-oriented business initiatives, please visit our website
at [www.RainbowBioSciences.com].
For investment information and performance data on the company,
please visit www.RainbowBioSciences.com/investors.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995: This news release contains forward-looking
information within the meaning of Section 27A of the Securities
Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended, including statements that
include the words "believes," "expects," "anticipate" or
similar expressions. Such forward-looking statements involve
known and unknown risks, uncertainties and other factors that
may cause the actual results, performance or achievements of
the company to differ materially from those expressed or
implied by such forward-looking statements. In addition,
description of anyone's past success, either financial or
strategic, is no guarantee of future success. This news release
speaks as of the date first set forth above and the company
assumes no responsibility to update the information included
herein for events occurring after the date hereof.

Follow this link:
RBCC Explores New Cures for Cancer, Brain Injuries & Headaches